Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II pilot study of intramuscular HE2000 in late-stage HIV infection at risk for opportunistic infections
ISRCTN81525828Phase 2Completed
- Sponsor
- Harbor Therapeutics, Inc.
- Start
- Nov 2000
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in human immunodeficiency virus infection (HIV) comparing HE2000 with Placebo (2 arms). Started Nov 2000; status: completed.
02
Drugs
16-bromoepiandrosterone
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on ISRCTN81525828.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN81525828.